The role of the hippocampus in the pathophysiology of major depression

Journal of Psychiatry and Neuroscience

Volumn 29, Issue 6, 2004, Pages 417-426

  Campbell, Stephanie ^a   MacQueen, Glenda ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY MEDICAL CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; BRAIN DERIVED NEUROTROPHIC FACTOR; CARBON 11; CYCLIC AMP; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; GLUCOCORTICOID; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; NEUROTROPHIN; SEROTONIN 1A RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AUTOPSY; COGNITIVE DEFECT; CONTROLLED STUDY; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; MAJOR DEPRESSION; MEMORY DISORDER; NERVE CELL NECROSIS; NERVOUS SYSTEM DEVELOPMENT; NEUROIMAGING; NEUROPSYCHOLOGICAL TEST; NONHUMAN; PATHOPHYSIOLOGY; REVIEW;

ANIMALS; CELL SURVIVAL; DEPRESSIVE DISORDER, MAJOR; FRONTAL LOBE; HIPPOCAMPUS; HUMANS; MEMORY DISORDERS; NERVE GROWTH FACTORS; NERVE NET; NERVE REGENERATION; NEURONS; TEMPORAL LOBE;

EID: 11344249233     PISSN: 11804882     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (121)

1. Drevets WC. Prefrontal cortical-amygdalar metabolism in major depression. Ann N Y Acad Sci 1999;877:614-37.
2. Czeh B, Michaelis T, Watanabe T, Frahm J, de Biurrun G, van Kampen M, et al. Stress-induced changes in cerebral metabolites, hippocampal volume, and cell proliferation are prevented by antidepressant treatment with tianeptine. Proc Natl Acad Sci U S A 2001;98:12796-801.
3. Duvernoy HM. The human hippocampus: functional anatomy, vascularization and serial sections with MRI. 2nd ed. Berlin: Springer-Verlag; 1998.
4. Fritschy JM, Weinmann O, Wenzel A, Benke D. Synapse-specific localization of NMDA and GABA(A) receptor subunits revealed by antigen-retrieval immunohistochemistry. J Comp Neurol 1998;390:194-210.
5. Sudweeks SN, Yakel JL. Functional and molecular characterization of neuronal nicotinic ACh receptors in rat CA1 hippocampal neurons. J Physiol 2000;527(Pt 3):515-28.
6. Sudweeks SN, Hooft JA, Yakel JL. Serotonin 5-HT(3) receptors in rat CA1 hippocampal interneurons: functional and molecular characterization. J Physiol 2002;544:715-26.
7. Barnes NM, Sharp T. A review of central 5-HT receptors and their function. Neuropharmacology 1999;38:1083-152.
8. Hoyer D, Clarke DE, Fozard JR, Hartig PR, Martin GR, Mylecharane EJ, et al. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol Rev 1994;46(2):157-203.
9. Vizi ES, Kiss JP. Neurochemistry and pharmacology of the major hippocampal transmitter systems: synaptic and nonsynaptic interactions. Hippocampus 1998;8:566-607.
10. Freund TF, Buzsaki G. Interneurons of the hippocampus. Hippocampus 1996;6:347-470.
11. Zola-Morgan S, Squire LR, Amaral DG. Human amnesia and the medial temporal region: enduring memory impairment following a bilateral lesion limited to field CA1 of the hippocampus. J Neurosci 1986;6:2950-67.
12. Rempel-Clower NL, Zola SM, Squire LR, Amaral DG. Three cases of enduring memory impairment after bilateral damage limited to the hippocampal formation. J Neurosci 1996;16:5233-55.
13. Alvarez P, Squire LR. Memory consolidation and the medial temporal lobe: a simple network model. Proc Natl Acad Sci U S A 1994;91:7041-5.
14. Moser MB, Moser EI. Functional differentiation in the hippocampus. Hippocampus 1998;8:608-19.
15. Herman JP, Dolgas CM, Carlson SL. Ventral subiculum regulates hypothalamo-pituitary-adrenocortical and behavioural responses to cognitive Stressors. Neuroscience 1998;86:449-59.
16. Bogerts B, Ashtari M, Degreef G, Alvir JM, Bilder RM, Lieberman JA. Reduced temporal limbic structure volumes on magnetic resonance images in first episode schizophrenia. Psychiatry Res 1990;35:1-13.
17. Bogerts B, Lieberman JA, Ashtari M, Bilder RM, Degreef G, Lerner G, et al. Hippocampus-amygdala volumes and psychopathology in chronic schizophrenia. Biol Psychiatry 1993;33: 236-46.
18. Breier A, Buchanan RW, Elkashef A, Munson RC, Kirkpatrick B, Gellad F. Brain morphology and schizophrenia: a magnetic resonance imaging study of limbic, prefrontal cortex, and caudate structures. Arch Gen Psychiatry 1992;49:921-6.
19. Bryant NA, Buchanan RW, Vladar K, Breier A, Rothman M. Gender differences in temporal lobe structures of patients with schizophrenia: a volumetric MRI study. Am J Psychiatry 1999;156:603-9.
20. Razi K, Greene KP, Sakuma M, Ge S, Kushner M, DeLisi LE. Reduction of the parahippocampal gyrus and the hippocampus in patients with chronic schizophrenia. Br J Psychiatry 1999;174:512-9.
21. Shenton ME, Kikinis R, Jolesz FA, Pollack SD, LeMay M, Wible CG, et al. Abnormalities of the left temporal lobe and thought disorder in schizophrenia. A quantitative magnetic resonance imaging study. N Engl J Med 1992;327:604-12.
22. Wright IC, Rabe-Hesketh S, Woodruff PWR, David AS, Murray RM, Bullmore ET. Meta-analysis of regional brain volumes in schizophrenia. Am J Psychiatry 2000;157:16-25.
23. MacQueen GM, Campbell S, McEwen BS, Macdonald K, Amano S, Joffe RT, et al. Course of illness, hippocampal function, and hippocampal volume in major depression. Proc Natl Acad Sci U S A 2003;100:1387-92.
24. Vythilingam M, Heim C, Newport J, Miller AH, Anderson E, Bronen R, et al. Childhood trauma associated with smaller hippocampal volume in women with major depression. Am J Psychiatry 2002;159:2072-80.
25. Frodl T, Meisenzahl EM, Zetzche T, Born C, Groll C, Jager M, et al. Hippocampal changes in patients with a first episode of major depression. Am J Psychiatry 2002;159:1112-8.
26. Steffens DC, Byrum CE, McQuoid DR, Greenberg DL, Payne ME, Blitchington TF, et al. Hippocampal volume in geriatric depression. Biol Psychiatry 2000;48:301-9.
27. Mervaala E, Fohr J, Kononen M, Valkonen-Korhonen M, Vainio P, Partanen K, et al. Quantitative MRI of the hippocampus and amygdala in severe depression. Psychol Med 2000;30: 117-25.
28. Bremner JD, Randall P, Scott TM, Bronen RA, Seibyl JP, Southwick SM, et al. MRI-based measurement of hippocampal volume in patients with combat-related posttraumatic stress disorder. Am J Psychiatry 1995;152:973-81.
29. Sheline YI, Sanghavi M, Mintun MA, Gado MH. Depression duration but not age predicts hippocampal volume loss in medically healthy women with recurrent major depression. J Neurosci 1999;19:5034-43.
30. Sheline YI, Wang PW, Gado MH, Csernansky JG, Vannier MW. Hippocampal atrophy in recurrent major depression. Proc Natl Acad Sci U S A 1996;93:3908-13.
31. Beyer JL, Krishnan KR. Volumetric brain imaging findings in mood disorders. Bipolar Disord 2002;4:89-104.
32. Magarinos AM, Deslandes A, McEwen BS. Effects of antidepressants and benzodiazepine treatments on the dendritic structure of CA3 pyramidal neurons after chronic stress. Eur J Pharmacol 1999;371:113-22.
33. Malberg JE, Eisch AJ, Nestler EJ, Duman RS. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J Neurosci 2000;20:9104-10.
34. Rajkowska G. Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells. Biol Psychiatry 2000; 48:766-77.
35. McEwen BS. Stress and hippocampal plasticity. Annu Rev Neurosci 1999;22:105-22.
36. Cameron HA, McKay RD. Restoring production of hippocampal neurons in old age. Nat Neurosci 1999;2:894-7.
37. Rogatsky I, Trowbridge JM, Garabedian MJ. Glucocorticoid receptor-mediated cell cycle arrest is achieved through distinct cell-specific transcriptional regulatory mechanisms. Mol Cell Biol 1997;17:3181-93.
38. Cosi C, Spoerri PE, Comelli MC, Guidolin D, Skaper SD. Glucocorticoids depress activity-dependent expression of BDNF mRNA in hippocampal neurones. Neuroreport 1993;4:527-30.
39. Carroll BJ. The dexamethasone test for melancholia. Br J Psychiatry 1982;140:292-304.
40. Kalin NH, Risch SC, Janowsky DS, Murphy DL. Use of dexamethasone suppression test in clinical psychiatry. J Clin Psychopharmacol 1981;1:64-9.
41. Maes M, de Ruyter M, Suy E. Cortisol response to dexamethasone and noradrenergic function in depression. Acta Psychiatr Scand 1987;75:171-5.
42. Young EA, Haskett RF, Grunhaus L, Pande A, Weinberg VM, Watson SJ, et al. Increased evening activation of the hypothalamic-pituitary-adrenal axis in depressed patients. Arch Gen Psychiatry 1994;51:701-7.
43. Sapolsky RM. The possibility of neurotoxicity in the hippocampus in major depression: a primer on neuron death. Biol Psychiatry 2000;48:755-65.
44. Bremner JD. Brain pathways in stress processing. Biol Psychiatry 2002;51:91S-92S.
45. McEwen BS. The neurobiology of stress: from serendipity to clinical relevance. Brain Res 2000;886:172-89.
46. Tuvnes FA, Steffenach HA, Murison R, Moser MB, Moser EI. Selective hippocampal lesions do not increase adrenocortical activity. J Neurosci 2003;23:4345-54.
47. Duman RS. Synaptic plasticity and mood disorders. Mol Psychiatry 2002;7(Suppl 1):S29-S34.
48. Duman RS, Nakagawa S, Malberg J. Regulation of adult neurogenesis by antidepressant treatment. Neuropsychopharmacology 2001;25:836-44.
49. Young LT. Neuroprotective effects of antidepressant and mood stabilizing drugs. J Psychiatry Neurosci 2002;27:8-9.
50. MacQueen GM, Ramakrishnan K, Ratnasingan R, Chen B, Young LT. Desipramine treatment reduces the long-term behavioural and neurochemical sequelae of early maternal separation, Int J Neuropsychopharmacol 2003;6(4):391-6.
51. Young LT, Bakish D, Beaulieu S. The neurobiology of treatment response to antidepressants and mood stabilizing medications. J Psychiatry Neurosci 2002;27:260-5.
52. Stewart RJ, Chen B, Dowlatshahi D, MacQueen GM, Young LT. Abnormalities in the cAMP signaling pathway in post-mortem brain tissue from the Stanley Neuropathology Consortium. Brain Res Bull 2001;55:625-9.
53. Dowlatshahi D, MacQueen GM, Wang JF, Young LT. Increased temporal cortex CREB concentrations and antidepressant treatment in major depression. Lancet 1998;352:1754-5.
54. Blier P, De Montigny C. Current advances and trends in the treatment of depression. Trends Pharmacol Sci 1994;15:220-6.
55. Gould E, Beylin A, Tanapat P, Reeves A, Shors TJ. Learning enhances adult neurogenesis in the hippocampal formation. Nat Neurosci 1999;2:260-5.
56. Rasmusson AM, Shi L, Duman R. Downregulation of BDNF mRNA in the hippocampal dentate gyrus after re-exposure to cues previously associated with footshock. Neuropsychopharmacology 2002;27:133-42.
57. Chen B, Dowlatshahi D, MacQueen GM, Wang JF, Young LT. Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biol Psychiatry 2001; 50:260-5.
58. Bayer TA, Schramm M, Feldmann N, Knable MB, Falkai P. Antidepressant drug exposure is associated with mRNA levels of tyrosine receptor kinase B in major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry 2000;24:881-8.
59. Sheline YI, Gado M, Kraemer HC. Untreated depression and hippocampal volume loss. Am J Psychiatry 2003;160:1-3.
60. Cotter D, Mackay D, Chana G, Beasley C, Landau S, Everall IP. Reduced neuronal size and glial cell density in area 9 of the dorsolateral prefrontal cortex in subjects with major depressive disorder. Cereb Cortex 2002;12:386-94.
61. Ongur D, Drevets WC, Price JL. Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc Natl Acad Sci U S A 1998;95:13290-5.
62. Rajkowska GR, Miguel-Hidalgo JJ, Wei J, Dilley G, Pittman SD, Meltzer HY, et al. Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biol Psychiatry 1999;45:1085-98.
63. Sapolsky RM, Krey LC, McEwen BS. Prolonged glucocorticoid exposure reduces hippocampal neuron number: implications for aging. J Neurosci 1985;5:1222-7.
64. Sapolsky RM, Uno H, Rebert CS, Finch CE. Hippocampal damage associated with prolonged glucocorticoid exposure in primates. J Neurosci 1990;10:2897-902.
65. Uno H, Tarara R, Else JG, Suleman MA, Sapolsky RM. Hippocampal damage associated with prolonged and fatal stress in primates. J Neurosci 1989;9:1705-11.
66. Lucassen PJ, Muller MB, Holsboer F, Bauer J, Holtrop A, Wouda J, et al. Hippocampal apoptosis in major depression is a minor event and absent from subareas at risk for glucocorticoid overexposure. Am J Pathol 2001;158(2):453-68.
67. Muller MB, Lucassen PJ, Yassouridis A, Hoogendijk WJ, Holsboer F, Swaab DF. Neither major depression nor glucocorticoid treatment affects the cellular integrity of the human hippocampus. Eur J Neurosci 2001;14:1603-1612.
68. Dwork AJ. Postmortem studies of the hippocampal formation in schizophrenia. Schizophr Bull 1997;23:385-402.
69. Starkman MN, Giordani B, Gebarski SS, Berent S, Schork MA, Schteingart DE. Decrease in cortisol reverses human hippocampal atrophy following treatment of Cushing's disease. Biol Psychiatry 1999;46:1595-602.
70. Posener JA, Wang L, Price JL, Gado M, Province MA, Miller MI, et al. High-dimensional mapping of the hippocampus in depression. Am J Psychiatry 2003;160(1):83-9.
71. Rusch BD, Abercrombie HC, Oakes TR, Schaefer SM, Davidson RJ. Hippocampal morphometry in depressed patients and control subjects: relations to anxiety symptoms. Biol Psychiatry 2001;50:960-4.
72. Bremner JD, Narayan M, Anderson ER, Staib LH, Miller HL, Charney DS. Hippocampal volume reduction in major depression. Am J Psychiatry 2000;157:115-7.
73. Vakili K, Pillay SS, Lafer B, Fava M, Renshaw PF, Bonello-Cintron CM, et al. Hippocampal volume in primary unipolar major depression: a magnetic resonance imaging study. Biol Psychiatry 2000;47:1087-90.
74. Von Gunten A, Fox NC, Cipolotti L, Ron MA. A volumetric study of hippocampus and amygdala in depressed patients with subjective memory problems. J Neuropsychiatry Clin Neurosci 2000;12:493-8.
75. Ashtari M, Greenwald BS, Kramer-Ginsberg E, Hu J, Wu H, Patel M, et al. Hippocampal/amygdala volumes in geriatric depression. Psychol Med 1999;29:629-38.
76. Campbell S, Marriott M, Nahmias C, MacQueen GM. Lower hippocampal volume in patients suffering from depression: a meta-analysis. Am J Psychiatry 2004;161(4):598-607.
77. Pantel J, Schroder J, Essig M, Popp D, Dech H, Knopp MV, et al. Quantitative magnetic resonance imaging in geriatric depression and primary degenerative dementia. J Affect Disord 1997;42:69-83.
78. Zubenko GS, Sullivan P, Nelson JP, Belle SH, Huff J, Wolf GL. Brain imaging abnormalities in mental disorders of late life. Arch Neurol 1990;47:1107-11.
79. Volz HP, Rzanny R, Rossger G, Hubner G, Kreitschmann-Andermahr I, Kaiser WA, et al. 31Phosphorus magnetic resonance spectroscopy of the dorsolateral prefrontal region in schizophrenics - a study including 50 patients and 36 controls. Biol Psychiatry 1998;44(6):399-404.
80. Gilbertson MW, Shenton ME, Ciszewski A, Kasai K, Lasko NB, Orr SP, et al. Smaller hippocampal volume predicts pathologic vulnerability to psychological trauma. Nat Neurosci 2002;5:1242-7.
81. Teicher MH, Andersen SL, Polcari A, Anderson CM, Navalta CP. Developmental neurobiology of childhood stress and trauma. Psychiatr Clin North Am 2002;25:397-426.
82. Bremner JD, Randall P, Vermetten E, Staib L, Bronen RA, Mazure C, et al. Magnetic resonance imaging-based measurement of hippocampal volume in posttraumatic stress disorder related to childhood physical and sexual abuse-a preliminary report. Biol Psychiatry 1997;41:23-32.
83. Shah PJ, Ebmeier KP, Glabus MF, Goodwin GM. Cortical grey matter reductions associated with treatment resistant chronic unipolar depression. Controlled magnetic resonance imaging study. Br J Psychiatry 1998;172:527-32.
84. McCarley RW, Shenton ME, Kasai K, Hirayasu Y, Salisbury DF. Progression of grey matter loss after first-episode in schizophrenia but not in bipolar psychoses. Biol Psychiatry 2002;51:11S.
85. McDonough L, Mandler JM, McKee RD, Squire LR. The deferred imitation task as a nonverbal measure of declarative memory. Proc Natl Acad Sci U S A 1995;92:7580-4.
86. Scoville WB, Milner B. Loss of recent memory after bilateral hippocampal lesions. 1957. J Neuropsychiatry Clin Neurosci 2000;12:103-13.
87. Mishkin M, Suzuki WA, Gadian DG, Vargha-Khadem F. Hierarchical organization of cognitive memory. Philos Trans R Soc Lond B Biol Sci 1997;352:1461-7.
88. Mishkin M, Appenzeller T. The anatomy of memory. Sci Am 1987;256:80-9.
89. Zola-Morgan S, Squire LR, Ramus SJ. Severity of memory impairment in monkeys as a function of locus and extent of damage within the medial temporal lobe memory system. Hippocampus 1994;4:483-95.
90. Buckner RL, Petersen SE, Ojemann JG, Miezin FM, Squire LR, Raichle ME. Functional anatomical studies of explicit and implicit memory retrieval tasks. J Neurosci 1995;15:12-29.
91. Schacter DL, Savage CR, Alpert NM, Rauch SL, Alpert MS. The role of hippocampus and frontal cortex in age-related memory changes: a PET study. Neuroreport 1996;7:1165-9.
92. Bernard F, Desgranges B, Platel H, Baron JC, Eustache F. Contributions of frontal and medial temporal regions to verbal episodic memory: a PET study. Neuroreport 2001;12:1737-41.
93. Bremner JD, Vythilingam M, Vermetten E, Southwick SM, McGlashan T, Staib LH, et al. Neural correlates of declarative memory for emotionally valenced words in women with post-traumatic stress disorder related to early childhood sexual abuse. Biol Psychiatry 2003;53:879-89.
94. Deckersbach T, Reilly-Harrington N, Clark L, Goodwin G, Savage CR, Dougherty DD, et al. Characteristics and functional anatomy of episodic memory impairment in bipolar disorder. Biol Psychiatry 2002;51:30S.
95. Owen AM, Doyon J, Petrides M, Evans AC. Planning and spatial working memory: a positron emission tomography study in humans. Eur J Neurosci 1996;8:353-64.
96. Mayes AR, Montaldi D. Exploring the neural bases of episodic and semantic memory: the role of structural and functional neuroimaging. Neurosci Biobehav Rev 2001;25:555-73.
97. Fletcher PC, Henson RN. Frontal lobes and human memory: insights from functional neuroimaging. Brain 2001;124:849-81.
98. Zakzanis KK, Leach L, Kaplan E. On the nature and pattern of neurocognitive function in major depressive disorder. Neuropsychiatry Neuropsychol Behav Neurol 1998;11:111-9.
99. Weingartner H, Cohen RM, Murphy DL, Martello J, Gerdt C. Cognitive processes in depression. Arch Gen Psychiatry 1981; 38:42-7.
100. Roediger HL III, McDermott KB. Depression and implicit memory: a commentary. J Abnorm Psychol 1992;101:587-91.
101. Bazin N, Perruchet P, De Bonis M, Feline A. The dissociation of explicit and implicit memory in depressed patients. Psychol Med 1994;24:239-45.
102. Hertel PT, Hardin TS. Remembering with and without awareness in a depressed mood: evidence of deficits in initiative. J Exp Psychol Gen 1990;119:45-59.
103. Watkins PC, Mathews A, Williamson DA, Fuller RD. Mood-congruent memory in depression: Emotional priming or elaboration? J Abnorm Psychol 1992;101:581-6.
104. Danion JM, Willard-Schroeder D, Zimmermann MA, Grange D, Schlienger JL, Singer L. Explicit memory and repetition priming in depression. Preliminary findings. Arch Gen Psychiatry 1991;48:707-11.
105. Buchanan RW, Vladar K, Barta PE, Pearlson GD. Structural evaluation of the prefrontal cortex in schizophrenia. Am J Psychiatry 1998;155:1049-55.
106. Curtis VA, Bullmore ET, Brammer MJ, Wright IC, Williams SC, Morris RG, et al. Attenuated frontal activation during a verbal fluency task in patients with schizophrenia. Am J Psychiatry 1998;155:1056-63.
107. Purcell R, Maruff P, Kyrios M, Pantelis C. Neuropsychological deficits in obsessive-compulsive disorder: a comparison with unipolar depression, panic disorder, and normal controls. Arch Gen Psychiatry 1998;55:415-23.
108. Goodwin GM. Neuropsychological and neuroimaging evidence for the involvement of the frontal lobes in depression. J Psychopharmacol 1997;11:115-22.
109. Clark L, Iversen SD, Goodwin GM. Sustained attention deficit in bipolar disorder. Br J Psychiatry 2002;180:313-9.
110. Harmer CJ, Clark L, Grayson L, Goodwin GM. Sustained attention deficit in bipolar disorder is not a working memory impairment in disguise. Neuropsychologia 2002;40:1586-90.
111. 1A receptors on human explicit memory. Am J Psychiatry 2003;160:334-40.
112. Kimbrell TA, Ketter TA, George MS, Little JT, Benson BE, Willis MW, et al. Regional cerebral glucose utilization in patients with a range of severities of unipolar depression. Biol Psychiatry 2002;51:237-52.
113. Saxena S, Brody AL, Ho ML, Alborzian S, Maidment KM, Zohrabi N, et al. Differential cerebral metabolic changes with paroxetine treatment of obsessive-compulsive disorder vs major depression. Arch Gen Psychiatry 2002;59:250-61.
114. Drevets WC, Price JL, Bardgett ME, Reich T, Todd RD, Raichle ME. Glucose metabolism in the amygdala in depression: relationship to diagnostic subtype and plasma cortisol levels. Pharmacol Biochem Behav 2002;71:431-47.
115. Grady CL, Keightley ML. Studies of altered social cognition in neuropsychiatric disorders using functional neuroimaging. Can J Psychiatry 2002;47:327-36.
116. Liotti M, Mayberg HS. The role of functional neuroimaging in the neuropsychology of depression. J Clin Exp Neuropsychol 2001;23:121-36.
117. Videbech P. PET measurements of brain glucose metabolism and blood flow in major depressive disorder: a critical review. Acta Psychiatr Scand 2000;101:11-20.
118. Videbech P, Ravnkilde B, Pedersen TH, Hartvig H, Egander A, Clemmensen K, et al. The Danish PET/depression project: clinical symptoms and cerebral blood flow. A regions-of-interest analysis. Acta Psychiatr Scand 2002;106:35-44.
119. Videbech P, Ravnkilde B, Pedersen AR, Egander A, Landbo B, Rasmussen NA, et al. The Danish PET/depression project: PET findings in patients with major depression. Psychol Med 2001;31:1147-58.
120. Kennedy SH, Evans KR, Kruger S, Mayberg HS, Meyer JH, McCann S, et al. Changes in regional brain glucose metabolism measured with positron emission tomography after paroxetine treatment of major depression. Am J Psychiatry 2001;158:899-905.
121. Mayberg HS, Silva JA, Brannan SK, Tekell JL, Mahurin RK, McGinnis S, et al. The functional neuroanatomy of the placebo effect. Am J Psychiatry 2002;159:728-37.